Head-to-head · WeighScore
Society of You vs Tablet Health
The verdict
Society of You takes it — 62.4/100 to 47.6/100.
Society of You grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Society of You is a US telehealth brand (Society Management Group) offering compounded GLP-1 weight-loss medication filled through named partner pharmacies (Emerald and Striker).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Society of You | Tablet Health |
|---|---|---|
| WeighScore | 62.4/100 | 47.6/100 |
| Grade | C | C |
| Scorecard rank | #271 | #495 |
| Semaglutide | $279/mo (promotional rate, compounded) | Not disclosed |
| Tirzepatide | $425/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #271 · C
Strengths
- Two named partner pharmacies disclosed (Emerald Pharmacy, Striker Pharmacy)
- Injectable and oral tirzepatide plus semaglutide options
- Discounted first-month introductory pricing
Where it loses points
- Standard rates are high once the intro month ends ($279-$425/mo)
- Service-area states are not published on the marketing site
- Support details are not disclosed publicly
Graded #495 · C
Strengths
- LegitScript Certified
- Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
- Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
- Mid-tier pricing starting $179–$299/mo across all four product variants
- No commitment — cancel anytime
Where it loses points
- States served not published — you must complete the intake quiz to learn eligibility
- No founder, CEO, medical director, or pharmacist-in-charge named anywhere
- No BBB profile found
- Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.